BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27977318)

  • 21. Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia.
    Haitsma JJ; Schultz MJ; Hofstra JJ; Kuiper JW; Juco J; Vaschetto R; Levi M; Zhang H; Slutsky AS
    Eur Respir J; 2008 Dec; 32(6):1599-606. PubMed ID: 18768578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
    Choi G; Hofstra JJ; Roelofs JJ; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; van der Poll T; Levi M; Schultz MJ
    Crit Care Med; 2008 Jan; 36(1):204-10. PubMed ID: 18090375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effects of three dosages of nebulized unfractionated heparin on alveolar coagulation and tissue inflammation injury in endotoxin-induced acute lung injury rat model].
    Wang ZY; Wu SN; Zhu X
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Oct; 24(10):612-5. PubMed ID: 23040779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of pulmonary neutrophil trafficking during endotoxemia is dependent on the stimulus for migration.
    Wagner JG; Driscoll KE; Roth RA
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):769-76. PubMed ID: 10101010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury.
    Kipnis E; Guery BP; Tournoys A; Leroy X; Robriquet L; Fialdes P; Neviere R; Fourrier F
    Shock; 2004 May; 21(5):444-51. PubMed ID: 15087821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infections.
    Kasetty G; Smeds E; Holmberg E; Wrange L; Adikesavan S; Papareddy P
    BMC Microbiol; 2016 Jun; 16(1):129. PubMed ID: 27349742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.
    van den Boogaard FE; van 't Veer C; Roelofs JJ; Meijers JC; Schultz MJ; Broze GJ; van der Poll T
    Thromb Haemost; 2015 Jul; 114(1):115-22. PubMed ID: 25832548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans.
    van der Poll T; Levi M; Nick JA; Abraham E
    Am J Respir Crit Care Med; 2005 May; 171(10):1125-8. PubMed ID: 15750041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.
    Sabharwal AK; Bajaj SP; Ameri A; Tricomi SM; Hyers TM; Dahms TE; Taylor FB; Bajaj MS
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):758-67. PubMed ID: 7881667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.
    Elsayed YA; Nakagawa K; Kamikubo YI; Enjyoji KI; Kato H; Sueishi K
    Am J Clin Pathol; 1996 Nov; 106(5):574-83. PubMed ID: 8929465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations.
    Tuinman PR; Dixon B; Levi M; Juffermans NP; Schultz MJ
    Crit Care; 2012 Dec; 16(2):R70. PubMed ID: 22546487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.
    Carr C; Bild GS; Chang AC; Peer GT; Palmier MO; Frazier RB; Gustafson ME; Wun TC; Creasey AA; Hinshaw LB
    Circ Shock; 1994 Nov; 44(3):126-37. PubMed ID: 7600636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide.
    Hoogerwerf JJ; de Vos AF; Levi M; Bresser P; van der Zee JS; Draing C; von Aulock S; van der Poll T
    Crit Care Med; 2009 Feb; 37(2):619-25. PubMed ID: 19114879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats.
    Schoots IG; Levi M; van Vliet AK; Maas AM; Roossink EH; van Gulik TM
    Crit Care Med; 2004 Jun; 32(6):1375-83. PubMed ID: 15187522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor of nuclear factor-κB, SN50, attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model.
    Chian CF; Chiang CH; Chuang CH; Liu SL
    Transl Res; 2014 Mar; 163(3):211-20. PubMed ID: 24646628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
    van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
    Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.
    Tang H; Ivanciu L; Popescu N; Peer G; Hack E; Lupu C; Taylor FB; Lupu F
    Am J Pathol; 2007 Sep; 171(3):1066-77. PubMed ID: 17640967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia.
    de Beer F; Lagrand W; Glas GJ; Beurskens CJ; van Mierlo G; Wouters D; Zeerleder S; Roelofs JJ; Juffermans NP; Horn J; Schultz MJ
    Cell Biochem Biophys; 2016 Dec; 74(4):545-552. PubMed ID: 27683129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
    Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
    J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.